Elevance Health, Inc. (ELV)
NYSE: ELV · Real-Time Price · USD
385.73
+7.37 (1.95%)
At close: Jul 28, 2026, 4:00 PM EDT
385.50
-0.23 (-0.06%)
After-hours: Jul 28, 2026, 7:39 PM EDT

Elevance Health Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
4,9475,6615,9715,9915,8886,149
Depreciation & Amortization
1,7121,7451,5461,3931,6751,302
Stock-Based Compensation
244276191289264255
Other Adjustments
-66684-28571149-465
Change in Receivables
-260-2,526-683-1,762-2,510-2,138
Changes in Accounts Payable
1,714-720-2721,640824719
Changes in Income Taxes Payable
-412-297404-103-338140
Changes in Unearned Revenue
79-15-113290-42-113
Changes in Other Operating Activities
1,1621,105-2,554752,4892,515
Operating Cash Flow
7,4644,2905,8088,0618,3998,364
Operating Cash Flow Growth
15.65%-26.14%-27.95%-4.02%0.42%-21.74%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-1,175-1,116-1,256-1,296-1,152-1,087
Purchases of Investments
-14,791-15,026-17,986-16,236-24,946-18,669
Proceeds from Sale of Investments
13,71815,09518,57213,53622,60814,613
Cash Acquisitions
3988-4,809-1,552-649-3,476
Proceeds from Business Divestments
--363---
Other Investing Activities
-158-509-2978-421-1,019
Investing Cash Flow
-2,243-1,344-5,167-5,572-4,560-9,638

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
2,3301,5052752251,3651,375
Short-Term Debt Repaid
-2,690-1,720-135-265-1,675-1,050
Net Short-Term Debt Issued (Repaid)
-360-215140-40-310325
Long-Term Debt Issued
-2,9917,7102,5743,0713,462
Long-Term Debt Repaid
-1,647-2,147-1,650-1,909-1,899-1,068
Net Long-Term Debt Issued (Repaid)
-1,6478446,0606651,1722,394
Issuance of Common Stock
12179221152182203
Repurchase of Common Stock
-2,705-2,605-2,900-2,676-2,316-1,900
Net Common Stock Issued (Repurchased)
-2,584-2,526-2,679-2,524-2,134-1,697
Common Dividends Paid
-1,507-1,529-1,508-1,395-1,229-1,104
Other Financing Activities
-4231,688-820-551,183505
Financing Cash Flow
-3,530-1,7381,193-3,349-1,318423

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-19-5-6-1-14-10
Net Cash Flow
1,6721,2031,828-8612,507-861

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
6,2893,1744,5526,7657,2477,277
Free Cash Flow Growth
17.84%-30.27%-32.71%-6.65%-0.41%-24.72%
FCF Margin
3.16%1.61%2.60%3.97%4.66%5.31%
Free Cash Flow Per Share
28.4614.1319.5428.5029.8529.49
Levered Free Cash Flow
6,0366,9939,9358,61110,21212,353
Unlevered Free Cash Flow
7,2196,2463,2567,9129,2798,950
SEC Filings: 10-K · 10-Q